Jyong Biotech Ltd stock is traded at $1.65, with a volume of 29,762. It is down -5.17% in the last 24 hours and down -18.32% over the past month. Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.
Previous Close:
$1.74
Open:
$1.64
24h Volume:
29,762
Relative Volume:
0.73
Market Cap:
$122.49M
Revenue:
-
Net Income/Loss:
-$4.67M
P/E Ratio:
-
EPS:
-$0.0635
Net Cash Flow:
-$3.62M
1W Performance:
-12.23%
1M Performance:
-18.32%
6M Performance:
-23.26%
1Y Performance:
-95.59%
1-Day Range:
$0.00$0.00
1-Week Range:
$1.62$2.02
52-Week Range:
$1.43$43.78
Jyong Biotech Ltd Stock (MENS) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS